FAQ Section What is GLP-1, and why is it important
However, insufficient pre-exercise glycogen causes protein degradation, glycogenolysis, muscle glycogen depletion, early tiredness, and lower training intensity (81, 84, 85)
Additional risk factors commonly present in patients prescribed GLP-1 receptor agonists include: Reduced physical activity and prolonged immobility Hypertension and other cardiovascular comorbidities Dyslipidaemia contributing to atherosclerosis Advanced age , as thrombotic risk increases with ageing Other important VTE risk factors include: Previous VTE or family history of clotting disorders Thrombophilia (inherited or acquired clotting disorders) Active cancer or cancer treatment Oestrogen-containing medications (HRT, combined oral contraceptives) Pregnancy and postpartum period Recent surgery, trauma or hospitalisation Long-haul travel with prolonged immobility Smoking When patients taking GLP-1 receptor agonists experience thrombotic events, it is important to consider these pre-existing risk factors as they often contribute significantly to clotting risk in this population
Because the digestive system absorbs semaglutide less efficiently than a direct injection, the pill dose is much higher in milligrams than the injection dose
It doesnt replace it
Effectiveness of semaglutide: a GLP-1 receptor agonist, semaglutide has also shown significant results in promoting weight loss, with clinical trials reporting an average reduction of about 15%
/assets/images/provider/photos/2766296.jpeg)
